New nanoparticles can perform gene editing in the lungs

A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.

AI-generated nanoparticles prove capable of delivering modern

Combinatorial design of nanoparticles for pulmonary mRNA delivery

Bioinspired Lipid Nanocarriers for RNA Delivery

Nanoparticles may correct genetic defects in cystic fibrosis lungs

New nanoparticles can perform gene-editing in the lungs

Sniffing nanoparticles loaded with mRNA could lead to advanced

Exploring nano-enabled CRISPR-Cas-powered strategies for efficient

Robust genome editing in adult vascular endothelium by

An mRNA COVID vaccine (and potentially more) with nanoparticles

New nanoparticles aid sepsis treatment in mice — Nano Magazine

Emerging Respiratory Treatments: Frontiers in Pulmonology

Can gene editing kill deadly diseases?, Features